Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 6377 - 6384 of 12015 results
MintzTech Guest Article: Letter to Jamie Dimon and Anyone Still Struggling to Understand Cryptocurrencies
January 15, 2018| Article| Viewpoint
Heightened stock market interest in cannabis persists
January 15, 2018| News
Individual Mandate Now Gone, G.O.P. Targets the One for Employers
January 14, 2018| News
A Federal Court Gets Opportunity to Weigh In on Prop 65 With a Little Help from Some Friends
January 11, 2018| Blog| Viewpoint
New Year’s Resolution #5: Four Employee Benefits Resolutions for 2018!
January 11, 2018| Blog| Viewpoint
CMS Guidance on Work Requirements for Medicaid Eligibility
January 11, 2018| Blog| Viewpoint
Overview of Recent U.S. Tax Reform Part I – Certain Significant Changes Impacting C-Corporations
January 11, 2018| Alert| Viewpoint
Upcoming Rule Would Curtail Blocking Exchange of Health Data
January 11, 2018| News
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
The Evolving Global Digital Infrastructure: Data Centers, AI, and the Next Wave of Connectivity
New York, NY
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|